E 6123

Latest Information Update: 10 Aug 1999

Price :
$50
*

* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

Originator
Eisai Co Ltd

Class
Antiallergics; Antiasthmatics

Mechanism of Action
Platelet activating factor inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

Discontinued
Asthma

Most Recent Events

10 Aug 1999
Discontinued-II for Asthma in Japan (PO)

14 Aug 1997
Profile reviewed

13 Feb 1995
Phase-II clinical trials for Asthma in Japan (PO)

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login
with a username/password associated to an account with a valid subscription